MiRagen Pockets $20M to Further miRNA-Based Drugs - Genetic Engineering News

Find a Doctor | Doctor Directory | General Medicine Resources Online

Provider Log In | Sign Up and Get Listed Today!

News

Medicine News » General Medicine News » MiRagen Pockets $20M to Further miRNA-Based Drugs - Genetic Engineering News

MiRagen Pockets $20M to Further miRNA-Based Drugs - Genetic Engineering News

Posted on April 24^th, 2012, 9:54 am

MiRagen Pockets $20M to Further miRNA-Based Drugs
Genetic Engineering News
Additionally, there are four drug compounds in target validation studies against peripheral arterial disease, cardiometabolic disease, vascular disease, and amyotrophic lateral sclerosis. Additionally, miRagen is coupling its expertise with outside ...

print this page email this page

Live General Medicine

Find a Doctor

Questions and Answers

General Medicine News

General Medicine

© Copyright 2009-12 LiveWebDoc.com All Rights Reserved.
Disclaimer: The material on this site is for informational purposes only and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Use at your own risk.